Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

NCT07017972 · tracked via the Priya Life Science USA tracker

Sponsor

Fairtility

Phase

Observational

Started

2025-06-20

Last updated

2025-08-07

Condition(s) studied

Fertility Disorders

Investigational drug(s) / intervention(s)

AI evaluation of embryos

AI evaluation of embryos: AI evaluation of embryos inside a time-lapse incubator.

Study summary

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software.

In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Eligibility

Sex

FEMALE

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: 1. Images and data of eggs or embryos available from egg retrievals by women undergoing standard egg-freezing or In vitro fertilization (IVF) treatments, using their own eggs or donor eggs. 2. Women at least 18 years of age. 3. Embryos or eggs cultured in a time-lapse incubator connected to the AI Embryo Viewer. Exclusion Criteria: * Women with no available own or donor eggs.

Primary outcome measure(s)

Area under the curve (AUC) will be quantified using logistic regression to assess EQ Score's prediction of utilization. — 7 days

Trial sites (1)

Facility	City	Region	Status
New England Fertility Institute	Stamford	Connecticut	Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07017972 on ClinicalTrials.gov ↗ ← All trials in the USA